Metraipolis › archive › dc_93e2da9ccfcb

Comparative efficacy of tirzepatide and glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes: a systematic… — Europe PMC PMID:41761267

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41761267
DOI: 10.1186/s12933-[numero omesso]-3
License (as archived): solo-consultazione
Archived: 2026-11-05T13:07:42.014Z
SHA-256 of the archived text: 980ab5ebab9cd4aef07ec4041cee42b40c8bd4d81bc1818db532298a852f91b9
Stable URL of this page: https://metraipolis.com/documento/dc_93e2da9ccfcb

How to cite

Comparative efficacy of tirzepatide and glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes: a systematic… — Europe PMC PMID:41761267 — Europe PMC (en), https://europepmc.org/article/MED/41761267 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_93e2da9ccfcb (Metraipolis archive dc_93e2da9ccfcb, sha256 980ab5ebab9cd4aef07ec4041cee42b40c8bd4d81bc1818db532298a852f91b9)

BibTeX

@misc{dc93e2da9ccfcb,
  title = {Comparative efficacy of tirzepatide and glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes: a systematic… — Europe PMC PMID:41761267},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41761267},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_93e2da9ccfcb; sha256 980ab5ebab9cd4aef07ec4041cee42b40c8bd4d81bc1818db532298a852f91b9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41761267. Agents can read the archived copy with the MCP tool read_document.